CNE1000052M6
CNE1000052M6
ANHUI HUAHENG BIOTECHNOLOGY CO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 4.84B EUR | 4.04B EUR | 7.09B EUR | 8.15B EUR |
Enterprise Value | 6.89B EUR | 5.99B EUR | 9.01B EUR | 9.92B EUR |
Valuation Multiples | ||||
Trailing P/E | 41.15x | 61.49x | 100.35x | 102.27x |
Forward P/E | 13.07x | -- | -- | -- |
Price to Sales | 1.61x | 1.75x | 3.16x | 3.78x |
Price to Book | 1.83x | 1.49x | 2.64x | 3.08x |
EV/Revenue | 2.29x | 2.6x | 4.02x | 4.6x |
EV/EBITDA | 16.6x | 68x | 95.6x | 86.15x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -10.92% | -11.25% | -7.19% | -5.29% |